Finance

Lists
1COV:FRA
Covestro AG
€60.20
+0.17%
(+0.10) 1D
Aug 4, 11:19:11 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1COV...
Open
€60.10
High
€60.70
Low
€60.10
Mkt. cap
12.62B
Avg. vol.
1.84K
Volume
110.00
52-wk high
€61.14
52-wk low
€54.10
EPS
-€3.39
Shares outstanding
168.94M
No. of employees
17K
Open
€60.10
High
€60.70
Low
€60.10
Mkt. cap
12.62B
Avg. vol.
1.84K
Volume
110.00
52-wk high
€61.14
52-wk low
€54.10
EPS
-€3.39
Shares outstanding
168.94M
No. of employees
17K
News stories
From sources across the web
Profile
Covestro AG is a German company producing polyurethane and polycarbonate raw materials. Products include isocyanates and polyols for cellular foams, thermoplastic polyurethane and polycarbonate pellets, as well as polyurethane based additives used in the formulation of coatings and adhesives. It is a Bayer spin-off formed in the fall of 2015 and was formerly called Bayer MaterialScience. The main industries served are automotive manufacturing and supply, electrical engineering and electronics, construction and home products, and sports and leisure. Their products include coatings and adhesives, polyurethanes that are used in thermal insulation, electrical housings, and as a component of footwear and mattresses, and polycarbonates such as Covestro's Makrolon, which are highly impact-resistant plastics. Covestro polyurethane was used in the 2014 official FIFA World Cup football. Before 2019, Covestro enjoyed rapid earnings growth following supply shortages of chemicals used in foams. Covestro shares were first offered on the Frankfurt Stock Exchange in October 2015. Bayer sold its entire remaining stake in May 2018, Bayer's pension fund had a 6.8% stake managed separately. Wikipedia
About Covestro AG
CEOMarkus Steilemann
Employees17.4K
FoundedSep 1, 2015
HeadquartersLeverkusen, North Rhine-Westphalia, Germany
SectorSpeciality chemicals
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.17B
2.92B
3.36B
3.36B
Cost of goods sold
2.68B
2.54B
2.74B
2.74B
Cost of revenue
2.68B
2.54B
2.74B
2.74B
Research and development expenses
81.00M
85.00M
83.50M
83.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
437.00M
454.00M
457.00M
457.00M
Operating expense
463.00M
575.00M
501.00M
501.00M
Total operating expenses
3.15B
3.12B
3.24B
3.24B
Operating income
25.00M
-205.00M
122.00M
122.00M
Other non operating income
-5.00M
18.00M
500.00K
500.00K
EBT including unusual items
-9.00M
-353.00M
103.00M
103.00M
EBT excluding unusual items
-9.00M
-223.00M
103.00M
103.00M
Income tax expense
37.00M
24.00M
41.50M
41.50M
Effective tax rate
-411.11%
-6.80%
40.29%
40.29%
Other operating expenses
-55.00M
36.00M
-39.50M
-39.50M
Net income
-47.00M
-378.00M
60.00M
60.00M
Net profit margin
-1.48%
-12.97%
1.78%
1.78%
Earnings per share
-0.25
-
-
-
Interest and investment income
9.00M
10.00M
12.00M
12.00M
Interest expense
-33.00M
-44.00M
-27.50M
-27.50M
Net interest expenses
-24.00M
-34.00M
-15.50M
-15.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
242.00M
-39.25M
334.50M
334.50M
Gain or loss from assets sale
-25.00M
-30.00M
-22.00M
-22.00M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps